Anti-FVIIa | Coagulation factor VIIa
Referencia AS00001-500
embalaje : 500ug
Marca : Agrisera
Contact local distributor :
Teléfono : +1 850 650 7790
Anti-FVIIa | Coagulation factor VIIa (500 µg)
Product no: AS00 001-500
AS00 001-500 | Clonality: Polyclonal | Host: Rabbit | Reactivity: Human
-
This product doesn't have any reviews.
| Immunogen: | Recombinant human Factor VIIa (NovoSeven ®, Novo Nordisk A/S Denmark) |
| Host: | Rabbit |
| Clonality: | Polyclonal |
| Purity: | Immunogen affinity purified IgG in PBS pH 7.4. |
| Format: | Lyophilized |
| Quantity: | 500 µg |
| Reconstitution: | For reconstitution add 500 µl of sterile water |
| Storage: | Store lyophilized/reconstituted at -20°C; once reconstituted make aliquots to avoid repeated freeze-thaw cycles. Please remember to spin the tubes briefly prior to opening them, to avoid any losses that might occur from material adhering to the cap or sides of the tube. |
| Tested applications: | Prothrombin assay with human plasma (PT), thrombin generation assay, inhibition assay with Factor VIIa with TF and a chromogenic substrate, inDirect ELISA (I-ELISA) |
| Recommended dilution: | 1 : 15 000 (I-ELISA) |
| Expected | apparent MW: | 52 kDa |
| Confirmed reactivity: | Human |
| Predicted reactivity: | Primates |
| Not reactive in: | No confirmed exceptions from predicted reactivity are currently known |
| Additional information: | No significant difference in binding to Factor VII and Factor VIIa. Antibody is purified to total IgG fraction, followed by purification on specific FVIIa column. |
| Background: | Factor VIIa (FVIIa) is a key serine protease involved in the initiation of the coagulation cascade. FVIIa requires tissue factor (TF), a membrane bound protein, as an essential cofactor for maximal activity towards its biological substrates Factor X, Factor IX and Factor VII (FVII). |
| Selected references: | Lopez-Vilchez et al. (2009). Traffic of rFVIIa through Endothelial Cells and Redistribution into Subendothelium: Implications for a Prolonged Hemostatic Effect. Journal of Coagulation Disorders, October 1: (1). (immunolocalization) |